[HTML][HTML] Lifting the mask on neurological manifestations of COVID-19
A Pezzini, A Padovani - Nature Reviews Neurology, 2020 - nature.com
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic spreads, it
is becoming increasingly evident that coronavirus disease 2019 (COVID-19) is not limited to …
is becoming increasingly evident that coronavirus disease 2019 (COVID-19) is not limited to …
SARS-CoV-2 triggering autoimmune diseases
L Mobasheri, MH Nasirpour, E Masoumi… - Cytokine, 2022 - Elsevier
Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of
reasons. Viruses are thought to be important environmental elements that contribute to the …
reasons. Viruses are thought to be important environmental elements that contribute to the …
Multiple sclerosis following SARS-CoV-2 infection
M Palao, E Fernández-Díaz, J Gracia-Gil… - Multiple sclerosis and …, 2020 - Elsevier
SARS-CoV-2 infection can produce neurological features. The most common are headache,
anosmia and dysgeusia but patients may also develop other central nervous system (CNS) …
anosmia and dysgeusia but patients may also develop other central nervous system (CNS) …
A case of possible atypical demyelinating event of the central nervous system following COVID-19
After the novel coronavirus disease outbreak first began in Wuhan, China, in December
2019, the viral epidemic has quickly spread across the world, and it is now a major public …
2019, the viral epidemic has quickly spread across the world, and it is now a major public …
[HTML][HTML] Elucidating the neuropathologic mechanisms of SARS-CoV-2 infection
M Pacheco-Herrero, LO Soto-Rojas… - Frontiers in …, 2021 - frontiersin.org
The current pandemic caused by the new severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus …
(SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus …
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
Background Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …
COVID‐19: Neuroimaging features of a pandemic
ABSTRACT BACKGROUND AND PURPOSE The ongoing Coronavirus Disease 2019
(COVID‐19) pandemic is caused by the novel severe acute respiratory syndrome …
(COVID‐19) pandemic is caused by the novel severe acute respiratory syndrome …
Letter to the editor regarding the viewpoint “evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic …
K Toljan - ACS chemical Neuroscience, 2020 - ACS Publications
Besides the heart, kidneys, and testes having been found as initial sites of angiotensin-
converting enzyme 2 (ACE2) expression, endothelial and neuronal presence was …
converting enzyme 2 (ACE2) expression, endothelial and neuronal presence was …
[HTML][HTML] Connecting neuroinflammation and neurodegeneration in multiple sclerosis: are oligodendrocyte precursor cells a nexus of disease?
MW Psenicka, BC Smith, RA Tinkey… - Frontiers in cellular …, 2021 - frontiersin.org
The pathology in neurodegenerative diseases is often accompanied by inflammation. It is
well-known that many cells within the central nervous system (CNS) also contribute to …
well-known that many cells within the central nervous system (CNS) also contribute to …
[HTML][HTML] Long-term neurological threats of COVID-19: a call to update the thinking about the outcomes of the coronavirus pandemic
A Pereira - Frontiers in neurology, 2020 - frontiersin.org
Since 11 March 2020, The World Health Organization has characterized coronavirus
disease 2019 (COVID-19), caused by SARS-CoV-2 (1) as a pandemic. The outbreak started …
disease 2019 (COVID-19), caused by SARS-CoV-2 (1) as a pandemic. The outbreak started …